Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-001511-20Phase 4Completed
Phase 4, open-label, single-arm trial of cefuroxime in surgical site infection (SSI), sponsored by Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences. Primary endpoint: Hospital discharge status. Started Apr 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-001511-20.